1 Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
2 CIBER Cardiovascular diseases (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain.
3 Division of Family Medicine and Primary Care, Department of Neurobiology, Care Science and Society, Karolinska Institute, Huddinge, Sweden.
4 Department of Clinical Sciences, Lund University, Malmö, Sweden.
5 Clinical Microbiomics A/S, Copenhagen, Denmark.
6 Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
7 Department of Medical Sciences, Clinical Epidemiology, Uppsala University, Uppsala, Sweden.
8 The George Institute for Global Health, University of New South Wales, Sydney, Australia.
9 The Wallenberg Laboratory/Department of Molecular and Clinical Medicine, Institute of Medicine, Gothenburg University and the Department of Cardiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
10 Department of Cardiology, Clinical Sciences, Lund University and Skåne University Hospital, Lund, Sweden.
11 Wallenberg Center for Molecular Medicine and Lund University Diabetes Center, Lund University, Lund, Sweden.
12 School of Health and Social Studies, Dalarna University, Falun, Sweden.
13 Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden. tove.fall@medsci.uu.se.